» Articles » PMID: 38421123

Entorhinal-based Path Integration Selectively Predicts Midlife Risk of Alzheimer's Disease

Abstract

Introduction: Entorhinal cortex (EC) is the first cortical region to exhibit neurodegeneration in Alzheimer's disease (AD), associated with EC grid cell dysfunction. Given the role of grid cells in path integration (PI)-based spatial behaviors, we predicted that PI impairment would represent the first behavioral change in adults at risk of AD.

Methods: We compared immersive virtual reality (VR) PI ability to other cognitive domains in 100 asymptomatic midlife adults stratified by hereditary and physiological AD risk factors. In some participants, behavioral data were compared to 7T magnetic resonance imaging (MRI) measures of brain structure and function.

Results: Midlife PI impairments predicted both hereditary and physiological AD risk, with no corresponding multi-risk impairment in episodic memory or other spatial behaviors. Impairments associated with altered functional MRI signal in the posterior-medial EC.

Discussion: Altered PI may represent the transition point from at-risk state to disease manifestation in AD, prior to impairment in other cognitive domains.

Citing Articles

An experimental framework for conjoint measures of olfaction, navigation, and motion as pre-clinical biomarkers of Alzheimer's disease.

Biljman K, Gozes I, Lam J, Li V J Alzheimers Dis Rep. 2025; 8(1):1722-1744.

PMID: 40034341 PMC: 11863766. DOI: 10.1177/25424823241307617.


Path integration impairments reveal early cognitive changes in Subjective Cognitive Decline.

Segen V, Kabir M, Streck A, Slavik J, Glanz W, Butryn M bioRxiv. 2025; .

PMID: 40027817 PMC: 11870602. DOI: 10.1101/2025.02.17.638583.


rTCT: Rodent Triangle Completion Task to facilitate translational study of path integration.

Duncan S, Rehman S, Sagen V, Choi I, Lawrence S, Kalani O bioRxiv. 2025; .

PMID: 39975325 PMC: 11838589. DOI: 10.1101/2025.02.04.636463.


Rotation errors in path integration are associated with Alzheimer's disease tau pathology: a cross-sectional study.

Colmant L, Quenon L, Huyghe L, Ivanoiu A, Gerard T, Lhommel R Alzheimers Res Ther. 2025; 17(1):34.

PMID: 39893494 PMC: 11786419. DOI: 10.1186/s13195-025-01679-w.


Predicting real-world navigation performance from a virtual navigation task in older adults.

Goodroe S, Fernandez Velasco P, Gahnstrom C, Wiener J, Coutrot A, Hornberger M PLoS One. 2025; 20(1):e0317026.

PMID: 39869655 PMC: 11771902. DOI: 10.1371/journal.pone.0317026.


References
1.
Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges J . Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2013; 36(3-4):242-50. DOI: 10.1159/000351671. View

2.
Ghebremedhin E, Schultz C, Braak E, Braak H . High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Exp Neurol. 1998; 153(1):152-5. DOI: 10.1006/exnr.1998.6860. View

3.
Ormond J, OKeefe J . Hippocampal place cells have goal-oriented vector fields during navigation. Nature. 2022; 607(7920):741-746. PMC: 9329099. DOI: 10.1038/s41586-022-04913-9. View

4.
Pereira J, Janelidze S, Stomrud E, Palmqvist S, van Westen D, Dage J . Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects. Brain. 2021; 144(9):2826-2836. PMC: 8557344. DOI: 10.1093/brain/awab163. View

5.
Braak H, Del Tredici K . The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. Brain. 2015; 138(Pt 10):2814-33. DOI: 10.1093/brain/awv236. View